(Alliance News) - Exprivia Spa has let it be known that the board of directors has approved the plan for the merger of Exprivia into Abaco3 Spa

The company announced that the BoD approved the exchange ratio, which corresponds to 36.62 Exprivia ordinary shares with a par value of EUR0.52 for each Abaco3 ordinary share with a par value of EUR1.00.

In execution of the merger, Abaco3 will carry out a share capital increase of up to EUR814,771.00 by issuing up to 814,771 shares.

Exprivia is in the red by 7.3 percent at EUR1.73 per share.

By Claudia Cavaliere, Alliance News reporter

Comments and questions to redazione@alliancenews.com

Copyright 2024 Alliance News IS Italian Service Ltd. All rights reserved.